Publication | Closed Access

Activation of GPR55 attenuates cognitive impairment and neurotoxicity in a mouse model of Alzheimer's disease induced by Aβ1–42 through inhibiting RhoA/ROCK2 pathway

Synaptic SignalingSocial SciencesOxidative StressRhoa/rock2 PathwayAlzheimer's DiseaseDegenerative PathologyNeurochemistryMouse ModelMolecular NeuroscienceBiochemistryNeuropharmacologyNeuroprotectionPharmacologyProtective MechanismsNeurodegenerative DiseasesCellular NeuroscienceNeuroscienceMolecular NeurobiologyMedicine